Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Diabetic Neuropathy - Overview
Diabetic Neuropathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Diabetic Neuropathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Diabetic Neuropathy - Companies Involved in Therapeutics Development
Achelios Therapeutics Inc
Angelini Group
Applied Therapeutics Inc
Are Pharmaceuticals Inc
Bionevia Pharmaceuticals
Bol Pharma
Bristol-Myers Squibb Co
Calchan Ltd
Celularity Inc
Cleveland Diabetes Care Inc
Commence Bio Inc
CSPC Pharmaceutical Group Ltd
Exodos Life Sciences Limited Partnership
Glycadia Inc
GNT Pharma Co Ltd
Grifols SA
Grunenthal GmbH
Immune Pharmaceuticals Inc
Jiangsu Aosaikang Pharmaceutical Co Ltd
Kineta Inc
Medifron DBT Co Ltd
Mitsubishi Tabe Pharma Corp
Omeros Corp
Praetego Inc
Reata Pharmaceuticals Inc
Seneca Biopharma Inc
Sichuan Haisco Pharmaceutical Co Ltd
Sonnet BioTherapeutics Inc
Sphaera Pharma Pte Ltd
WEX Pharmaceuticals Inc
Winsantor Inc
YD Life Science Co
Yuhan Corp
Zhejiang Pharmaceutical Co Ltd
Diabetic Neuropathy - Drug Profiles
Diabetic Neuropathy - Dormant Projects
Diabetic Neuropathy - Discontinued Products
Diabetic Neuropathy - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Diabetic Neuropathy, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019


List of Tables


Number of Products under Development for Diabetic Neuropathy, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Diabetic Neuropathy - Pipeline by Achelios Therapeutics Inc, H2 2019
Diabetic Neuropathy - Pipeline by Angelini Group, H2 2019
Diabetic Neuropathy - Dormant Projects, H2 2019
Diabetic Neuropathy - Dormant Projects, H2 2019 (Contd..1), H2 2019
Diabetic Neuropathy - Dormant Projects, H2 2019 (Contd..2), H2 2019
Diabetic Neuropathy - Discontinued Products, H2 2019